{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:01Z","timestamp":1772165701058,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100015851","name":"OPKO Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04361-3","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T09:48:38Z","timestamp":1754560118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["High-dose extended-release calcifediol successfully treated advanced secondary hyperparathyroidism in an end-stage kidney disease patient: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Akhtar","family":"Ashfaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Choe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Tabash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Strugnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles W.","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"4361_CR1","unstructured":"United States Renal Data System. 2024 USRDS Annual Data Report: Epidemiology of kidney disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease. 2024."},{"key":"4361_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.kisu.2017.04.001","volume":"7","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group","year":"2017","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease \u2013 mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1\u201359. https:\/\/doi.org\/10.1016\/j.kisu.2017.04.001.","journal-title":"Kidney Int Suppl"},{"key":"4361_CR3","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1159\/000450766","volume":"44","author":"SM Sprague","year":"2016","unstructured":"Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, Lee S, Petkovich PM, Bishop CW. Use of extended-release calcifediol to treat secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease. Am J Nephrol. 2016;44:316\u201325.","journal-title":"Am J Nephrol"},{"key":"4361_CR4","doi-asserted-by":"publisher","DOI":"10.1159\/000546615","author":"CW Bishop","year":"2025","unstructured":"Bishop CW, Choe J, Strugnell SA, Ashfaq A. Extended-release Calcifediol normalized 1,25-dihydroxyvitamin D and prevented progression of secondary hyperparathyroidism in hemodialysis patients in a pilot randomized clinical trial. Am J Nephrol. 2025. https:\/\/doi.org\/10.1159\/000546615.","journal-title":"Am J Nephrol"},{"key":"4361_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","volume":"96","author":"AC Ross","year":"2011","unstructured":"Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96:53\u20138. https:\/\/doi.org\/10.1210\/jc.2010-2704.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"4361_CR6","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ndt\/gfae293","volume":"40","author":"HS J\u00f8rgensen","year":"2025","unstructured":"J\u00f8rgensen HS, Vervloet M, Cavalier E, Bacchetta J, de Borst MH, Bover J, Cozzolino M, Ferreira AC, Hansen D, Herrmann M, de Jongh R, Mazzaferro S, Wan M, Shroff R, Evenepoel P. The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation \u2013 a European consensus statement. Nephrol Dial Transpl. 2025;40(4):797\u2013822.","journal-title":"Nephrol Dial Transpl"},{"key":"4361_CR7","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/jn\/135.2.317","volume":"135","author":"BW Hollis","year":"2005","unstructured":"Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005;135:317\u201322. https:\/\/doi.org\/10.1093\/jn\/135.2.317.","journal-title":"J Nutr"},{"key":"4361_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1525-139X.2005.18402.x","volume":"18","author":"MF Holick","year":"2005","unstructured":"Holick MF. Vitamin D for health and in chronic kidney disease. Sem Dial. 2005;18:266\u201375. https:\/\/doi.org\/10.1111\/j.1525-139X.2005.18402.x.","journal-title":"Sem Dial"},{"key":"4361_CR9","doi-asserted-by":"publisher","first-page":"S582","DOI":"10.1093\/ajcn\/88.2.582S","volume":"88","author":"G Jones","year":"2008","unstructured":"Jones G. The pharmacokinetics of vitamin D toxicity. Am J Clin Nutr. 2008;88:S582\u20136. https:\/\/doi.org\/10.1093\/ajcn\/88.2.582S.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"4361_CR10","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2215\/cjn.05490614","volume":"10","author":"G Jones","year":"2015","unstructured":"Jones G. Interpreting vitamin D assay results: proceed with caution. Clin J Am Soc Nephrol. 2015;10(2):331\u20134. https:\/\/doi.org\/10.2215\/cjn.05490614.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4361_CR11","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.semnephrol.2012.12.016","volume":"33","author":"C Bosworth","year":"2013","unstructured":"Bosworth C, de Boer IH. Impaired vitamin D metabolism in CKD. Semin Nephrol. 2013;33(2):158\u201368. https:\/\/doi.org\/10.1016\/j.semnephrol.2012.12.016.","journal-title":"Semin Nephrol"},{"issue":"10","key":"4361_CR12","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1093\/ckj\/sfab035","volume":"14","author":"J Bover","year":"2021","unstructured":"Bover J, Gunnarsson J, Csomor P, Kaiser E, Cianciolo G, Lauppe R. Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a metaanalysis. Clin Kidney J. 2021;14(10):2177\u201386.","journal-title":"Clin Kidney J"},{"key":"4361_CR13","doi-asserted-by":"publisher","DOI":"10.1159\/000499187","author":"SA Strugnell","year":"2019","unstructured":"Strugnell SA, Sprague SM, Ashfaq A, Petkovich M, Bishop CW. Rationale for raising current clinical practice guideline target for serum 25-hydroxyvitamin D in chronic kidney disease. Am J Nephrol. 2019. https:\/\/doi.org\/10.1159\/000499187.","journal-title":"Am J Nephrol"},{"issue":"3","key":"4361_CR14","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/ki.1988.190","volume":"34","author":"A Dusso","year":"1988","unstructured":"Dusso A, Lopez-Hilker S, Rapp N, Slatopolsky E. Extra-renal production of calcitriol in chronic renal failure. Kidney Int. 1988;34(3):368\u201375.","journal-title":"Kidney Int"},{"issue":"6","key":"4361_CR15","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1210\/jcem-59-6-1063","volume":"59","author":"BP Halloran","year":"1984","unstructured":"Halloran BP, Schaefer P, Lifschitz M, Levens M, Goldsmith RS. Plasma vitamin D metabolite concentrations in chronic renal failure: effect of oral administration of 25-hydroxyvitamin D3. J Clin Endocrinol Metab. 1984;59(6):1063\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"4361_CR16","doi-asserted-by":"publisher","unstructured":"Kahn SS, Petkovich M, Holden RM, Adams MA. Megalin and vitamin D metabolism-implications in non-renal tissues and kidney disease. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14183690.","DOI":"10.3390\/nu14183690"},{"issue":"1","key":"4361_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ndt\/gfaa195","volume":"36","author":"N Tabibzadeh","year":"2021","unstructured":"Tabibzadeh N, Karaboyas A, Robinson BM, Csomor PA, Spiegel DM, Evenepoel P, Jacobson SH, Ure\u00f1a-Torres P-A, Fukagawa M, Al Salmi I, Liang X, Pisoni RL, Young EW. The risk of medically uncontrolled secondary hyperparathyroidism depends on parathyroid hormone levels at haemodialysis initiation. Nephrol Dial Transpl. 2021;36(1):160\u20139.","journal-title":"Nephrol Dial Transpl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04361-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04361-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T15:10:30Z","timestamp":1757344230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04361-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4361"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04361-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6334832\/v1","asserted-by":"object"}]},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study (NCT03602261; Registration Date: 2018-07-25) was conducted in compliance with the principles of the Declaration of Helinski. The protocol was reviewed by Advarra Institutional Review Board (Columbia, MD; protocol reference number 00025201). All participants provided advance written informed consent for their participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participant described in this case report gave written informed consent for its publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors (A.A., J.C., S.T., S.A.S., L.L.J. and C.W.B.) are or have been employees, consultants or contractors of OPKO Health, Inc. and have no other conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"442"}}